diagnogene

Tests details, prices & order

Please find our tests details and prices below. You can contact us to obtain our conditions concerning prices reductions.

The client (laboratory/physician) has to send a sample attached to our order form to one of our certified partner laboratories - this laboratory will directly return the result to the client. There is a specific order form for each test. You may download our order forms by clicking on the desired test.

If you are interested in tests that we do not offer in our exhaustive list, please contact us - we have the possibility of proposing new tests upon request.

Enter Disease or OMIM or Mutation  

Analysis name 

OMIM 

Gene 

Mutation 

Technique 

Duration  

Material to be sent 

Test accreditation / EQA  

Laboratory accreditation / EQA  

Price (Euros)

Achondroplasia  

100800 

FGFR3 

c.1138G>A; c.1138G>C 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

290

Acute Myeloid Leukemia M1, M2 

 

FLT - 3  

Internal Tandem Duplication and Mutation D835 

PCR  

5 days 

4 micrograms DNA 

 

ISO 15189 

290

Acute Myeloid Leukemia, Mast Cell Leukemia, mastocytosis 

 

c - KIT 

mutations in exons 8, 11 and 17  

PCR and Sequencing 

12 days 

4 micrograms DNA 

 

 

460

Acyl - CoA dehydrogenase medium chain deficiency  

201450 

MCAD 

mutation A985G 

PCR and RFLP 

1 month 

2 micrograms DNA 

 

 

170

Adenomatosous polyposis of the colon 

175100 

APC 

whole gene 

Sequencing 

20-30 days 

2 micrograms DNA 

 

 

650

Adenomatosous polyposis of the colon 

 

MYH 

Sequencing 

Sequencing 

 

2 micrograms DNA 

 

 

1330

Adult Polycistic Kidney Disease  

#173900 

PKD1 

linkage analysis 

microsatellites 

30 - 60days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

880

Adult polycystic kidneys - PKD1, PKD2 

173900 

PKD1, PKD2 

2 whole genes  

Sequencing  

3 months 

2 micrograms DNA 

CLIA 

CLIA 

3900

Alagille syndrome  

118450 

JAG1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

3500

Alpha - galactosidase A (GLA)  

301500 

GLA 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL, CAP 

770

Alpha - thalassemia 

141800 

HBA 

deletion 3,7 KB 

RFLP's 

25 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Alpha - thalassemia 

#141750 

HBA2, Alpha Globin 

del 3,7 Kb MED del 4,2 Kb del 20,5 Kb HphI NcoI 

DNA extraction + amplification + hybridization 

15 days 

2 micrograms DNA 

 

 

190

Alpha - thalassemia deletion 3,7 Kb 

#141750 

HBA2, Alpha Globin 

del 3,7 Kb 

DNA extraction + amplification + electrophoresis 

15 days 

2 micrograms DNA 

 

 

148

Alpha - thalassemias  

141800 

Alpha - GLOBIN GENES  

3,7/ 20,5/ Med deletions 

Multiplex PCR 

2 weeks  

2 micrograms DNA 

 

CAP 

290

Alpha 1 antitrypsin deficiency  

107400 

PI  

HAPLOtype 

RFLP's 

20 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

440

Alport syndrome, autosomal recessive 

203780 

COL4A3 + COL4A4 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

15000

Alport syndrome, X - linked 

301050 

COL4A5 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

8880

Alzheimer disease I - (AD1)  

104760 

APP 

point mutation 

PCR - SSCP - DNA Sequencing 

3 days 

2 micrograms DNA 

 

CAP 

490

Alzheimer disease II - (AD2)  

104310 

APOE  

E2,E3,E4 alleles 

PCR - RFLP 

3 days 

2 micrograms DNA 

 

CAP 

130

Alzheimer disease II - all coding exons 

104760 

APP 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

550

Alzheimer disease PSN1  

104311 

PSN1 

regulatory region + entire coding region 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

4400

Alzheimer disease PSN2 

104300 

PSN2 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

380

Alzheimer, early onset, AD3 

104310 

Apo E 

HAPLOtype 

RFLP's 

15 days  

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Alzheimer, early onset, AD3 

104311 

PSEN1 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

770

Amino acid transporter responsible for LPI (SLC7A7)  

603593 

LPI 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

980

Amyotrophic Lateral Sclerosis, ALS1 

#105400 

SOD1 

mutations 

polymerase chain reaction sequence analysis  

10 days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

770

Angelman syndrome 

105830 

UBE3A 

all coding exons 

Sequencing 

 

2 micrograms DNA 

 

ISO 2001 

1200

Angiotensin I - converting enzyme (ACE)  

106180 

ACE1, DCP1 

Fragment analysis 

Fragment analysis 

2 - 4 weeks 

2 micrograms DNA 

DGKL 

DGKL,CAP 

150

Anion exchange protein (1SLC4A1)  

109270 

BND3, EMPB3, EPB3, AE1 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1100

Antithrombin 3 (SERPINC1)  

107300 

AT3, AT - III 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

590

Antithrombin Deficiency 

107300 

SERPINC1 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Antithrombin Deficiency 

107300 

SERPINC1 

Full gene analysis 

dHPLC & Sequencing 

30 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

880

Apert syndrome 

101200 

FGFR2 

M (S225W, P253R)  

Sequencing Ex8 ex10 

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Apert syndrome Acrocephalosyndactylya type I 

#101200 

FGFR2 

S252W/ F P253R 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

330

Apolipoprotein B - 100 Deficiency  

107730 

APOB 100 

R3500Q, R3500W, R3531C  

Sequencing 

4 days 

2 micrograms DNA 

 

 

175

Apolipoprotein C2(APOC2)  

207750 

APOC2 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

450

Aquaporin 2(AQP2)  

107777 

 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

450

Arginine vasopressin receptor 2 (AVPR2)  

300538 

ADHR, V2R, V2 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

490

Ashkenazi Jewish diseases panel 

 

HEX A, BLM, ASPA, SMPD1, IKBKAP, DYT1, MCOLN1, FANCC, F11, G6PC, BCKHDB, GJB2, MEFV, GDE (or Amylo-1,6-glucosidase), GBA and CFTR. 

83 mutations 

PCR and APEX 

1 month 

2,5 micrograms DNA 

 

ISO 9001:2000 

390

Autosomal Dominant Retinitis Pigmentosa 

600105, 608380 

Ca4, FSCN2, IMPDH1, NRL, PRPF3, PRPF31, PRPF8, RDS, RHO, ROM1, RP1, RP9, CRX 

341 positions 

PCR and APEX 

1 month 

2,5 micrograms DNA 

 

 

390

Autosomal Recessive Retinitis Pigmentosa 

 

CERKL, CNGA1, CNGB1, MERTK, PDE6A, PDE6B, PNR, RDH12, RGR, RLBP1, SAG, TULP1, CRB, RPE65, USH2A, USH3A 

 

PCR and APEX 

1 month 

6 micrograms DNA 

 

 

390

Azoo - oligozoospermia  

400003 

Yq11 

Y deletion  

PCR (promega Y deletion kit)  

6 - 8 weeks 

2 micrograms DNA 

EMQN 

in preparation 

400

Azoospermia_deletions (AZF regions) - microdeletions  

400003 

DAZ, KALY, RBM 

microdeletions 

Multiplex PCR 

1 week  

2 micrograms DNA 

 

CAP 

380

Bardet Biedl Syndrome 

 

BBS1, BBS2, BBS3, BBS4, BBS5, BBS6, BBS7, BBS8, BBS9, BBS10, PHF6, ALMS1, GNAS1 

248 mutations 

PCR and APEX 

1 month 

4 micrograms DNA 

 

ISO 9001:2000 

450

Barth syndrome 

302060 

TAZ 

 

point mutation analysis 

 

2 micrograms DNA 

 

 

1100

Beare - Stevenson syndrome 

#123790 

FGFR2 

S372C Y375C 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

240

Becker Muscular Dystrophy (BMD)  

300 376 310 200 

Dystrophin 

exon 3, 4, 6, 8, 12, 13, 16, 17, 19, 32, 34, 41, 42, 43, 44, 45, 47, 48, 49, 50, 51, 52, 60, pb pm 

Multiplex PCR 

1 month 

2 micrograms DNA 

EMQN - 2005 

 

400

Beckwith - Wiedemann 

130650 

CDKNC1 (p57)  

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 2001 

750

Beckwith - Wiedemann 

130650 

H19 

methylation 

 

30 days 

2 micrograms DNA 

 

ISO 2001 

290

Beckwith - Wiedemann 

130650 

LIT 1 

methylation 

 

30 days 

2 micrograms DNA 

 

ISO 2001 

290

Beckwith - Wiedemann 

130650 

 

microsatellite in 11p15.5 

 

30 days 

2 micrograms DNA 

 

ISO 2001 

390

Bernard - Soulier syndrome 

231200 

GP1BA, GP1BB & GP9 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Bernard - Soulier syndrome 

231200 

GP1BA, GP1BB & GP9 

Full gene analysis 

dHPLC & Sequencing 

60 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

1900

Beta - thalassemia 

#603902 

HBB, Beta - Globin 

Exon 1 + 2 + 3 Intron 1 + 2 

DNA extraction + amplification + sequence 

15 days 

2 micrograms DNA 

 

 

220

Beta Thalassemia 

191901 

Beta Thalassemia 

whole gene 

Sequencing 

10 days 

2 micrograms DNA 

 

 

345

Bloom Syndrome 

210900 

BLM 

BLM-ASH 

ASO 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Breast and Ovarian cancer (BRCA1 and BRCA2) 

113705, 600185 

BRCA 1 and BRCA 2 full genes screening 

TGCE (Temperature Gradient Capillary Electrophoresis; Transgenomics Inc.) + analysis of all exons and exons - introns boundaries with bidirectional sequencing of all variant profiles + MLPA (Multiplex Ligation-dependent Probe Amplification; MRC Holland) for major deletions or insertions. 

 

2 months 

2 micrograms DNA 

EMQN 

EMQN 

1200 Euro for 0 - 10 samples per month; 1150 Euro for 11 to 100 samples per month; 950 Euro for 101 samples per month and above

Breast and Ovarian cancer (BRCA1) 

113705 

BRCA1 

whole gene 

Sequencing + MLPA 

20-30 days 

2 micrograms DNA 

 

 

650

Breast and Ovarian cancer (BRCA2) 

600185 

BRCA2 

whole gene 

Sequencing + MLPA 

20-30 days 

2 micrograms DNA 

 

 

650

Brugada syndrome 

601144 

SCN5A 

Mutation hotspots 

Sequencing  

 

2 micrograms DNA 

ISO 17025 

ISO 17025 

3500

Calcium sensing receptor (CASR)  

601199 

PCAR1 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

770

Canavan Disease 

271900  

ASPA  

E285A, Y231X  

ASO 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Carbonic anhydrase 2(CA2)  

259730 

CA II 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

590

Cardiofaciocutaneus syndrome, CFC 

115150 

BRAF 

mutation screening of exons 6,11,12 

CSGE + Sequencing 

30 days 

5 micrograms DNA 

 

EMQN 

650

Cardiovascular and Alzheimer's risk - C112R, R158C 

107741 

APOE 

C112R, R158C 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

190

Cardiovascular risk 

602601 

LOX1, - 188C - T 

allelic variant 

polymerase chain reaction reverse dot blot hybridisation 

7 days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

220

Cardiovascular risk - Cys112Arg, Arg158Cys, Arg3500Gln 

107741 

APOE + APOB 

Cys112Arg, Arg158Cys, Arg3500Gln 

PCR and reverse hybridization 

2 weeks 

2 micrograms DNA 

 

 

260

Carnitine Palmitoyltransferase II  

650 

CPTII 

all coding exons 

Sequencing (all coding exons)  

< 2 months 

2 micrograms DNA 

 

in preparation 

800

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy (CADASIL)  

125310 

HOTCH3 

whole gene 

Sequencing 

3 months 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

2400

Ceroid lipofuscinosis neuronal 3 juvenile Batten disease (CLN3)  

204200 

CLN3  

exons 7 - 8 deletion 

PCR 

1 month 

2 micrograms DNA 

 

 

210

Ceroid Lipofuscinosis, neuronal type 6  

601780 

CLN6 

all coding exons 

Sequencing (all coding exons)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

Charcot - Marie - tooth 1A  

118220 

PMP22 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

890

Charcot - Marie - tooth 1B 

118200 

MPZ 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1390

Charcot - Marie - tooth 1E  

118300 

PMP22 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

990

Charcot - Marie - tooth 2I  

607677 

MPZ 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1390

Charcot - Marie - tooth 2J  

607736 

MPZ 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1390

Charcot - Marie - tooth disease type 1D  

607678 

EGR2 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

1100

Charcot - Marie - tooth disease type 4A  

214400 

GDAP1 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

700

Charcot - Marie - tooth disease type 4D 

601455 

NDRG1 

Lom mutation 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

440

Chemokine receptor (CCR5)  

601373 

CMKBR5 

deletion CCR5D32 

PCR 

1 month 

2 micrograms DNA 

 

 

210

Chloride channel 5 (CLCN5)  

300008 

CLCK2, K2, CLC5 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1440

Chronic Myelomonocytic Leukemia (CMML) , Essential Thrombocythemia, Hypereosinophilic syndrome, Myeloid metaplasia with myelofibrosis, Neutrophilic Leukemia (CNL) , Polycythemia vera, Systemic Mastocytosis, Myelodysplastic syndromes 

 

JAK2 

mutation V617F  

4 - primer ARMS PCR 

5 days 

4 micrograms DNA 

 

ISO 15189 

175

Chronic progressive external ophthalmoplegia (CPEO)  

590055 

MTTL2 

deletions 

 

1 week 

2 micrograms DNA 

 

 

165

CMTX - GJB1 - all coding exons 

302800 

GJB1 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

550

Coffin Lowry syndrome  

303600 

RSK2 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

3250

Collagen type IV, Alpha 3 (COL4A3)  

120070 

COL4A3 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1750

Collagen type IV, Alpha 4 (COL4A4)  

120131 

COL4A4 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1750

Collagen type IV, Alpha 5 (COL4A5)  

303630 

COL4A5 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1750

Combined FV & FVIII Deficiency 

227300 

LMAN1 & MCFD2 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Combined FV & FVIII Deficiency 

227300 

LMAN1 & MCFD2 

Full gene analysis 

dHPLC & Sequencing 

60 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

1800

Complement factor H (CFH)  

134370 

HF1, HF, FHL1 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1980

COMT activity  

116790 

COMT 

Val158Met 

PCR - RFLP  

1 week 

2 micrograms DNA 

 

CAP 

190

Congenital adrenal hyperplasia  

201910 

CYP21 

all coding exons 

Sequencing (all coding exons) , SB 

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

Cornelia De Lange syndrome 

122470 

NIPBL 

all coding exons 

DHPLC 

30 days 

2 micrograms DNA 

 

ISO 2001 

790

Coronary disease - ACE - Insertion/ deletion  

106180 

ACE  

Insertion/ deletion 

PCR - ASO 

3 days 

2 micrograms DNA 

 

CAP 

350

Coronary spasm susceptibility  

163729 

ecNOS  

788C/ T, 894 G/ T & intron 4 VNTR 

PCR - ASO  

2 weeks 

2 micrograms DNA 

 

CAP 

80

Crouzon syndrome 

123500 

FGFR2 

exons 8, 10 

Sequencing (exons 8, 10)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

400

CYP27B1 (25 - hydroxyvitaminD3 1 - Alpha - hydroxylase gene)  

264700 

P450C1 - Alpha, CYP1, VDDR, PDDR, VDD1, CP2B, CYP27B, P450C1, VDDRI, VDDRII 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL, CAP 

770

CYP2C19  

124029 

CYP2C19 

CYP2C19*2, 3 

PCR - RFLP 

2 weeks 

2 micrograms DNA 

 

CAP 

380

CYP3A5  

605325 

CYP3A5 

CYP3A5*1, 2, 3 

PCR - ASO 

2 weeks 

2 micrograms DNA 

 

CAP 

190

Cystathionine b - Synthase (CBS) gene 

236200 

CBS 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Cystathionine b - Synthase (CBS) gene 

236200 

CBS 

Full gene analysis 

dHPLC & Sequencing 

40 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

1600

Cystic fibrosis (33 mutations + poly T) 

219700 

CFTR/ ABCC7 

33 common mutation + poly T: G85E; 394delTT; 621+1G?T; R117H; I148T; 711+1G?T; 1078delT; R347P; R347H; R334W; Polimorfismo Poly-T; A455E; DI507; DF508; 1717-1G?A; V520F; G542X; S549N; S549R; G551D; R553X; R560T; 1898+1 G?A; 2183AA?G; 2184delA; 2789 +5G?A; 3120+1 G?A ; R1162X; 3659delC; 3849+10KbC?T; 3876delA; W1282X; 3905insT; N1303K  

PCR/ OLA; ARMS - PCR 

7-10 days 

2 micrograms DNA 

CE marked kit, CF Consortium 

ISO 17025 / EMQN, CF Consortium, SAS 

155

Cystic fibrosis (CF and CBAVD) 

602421 

CFTR 

246 positions 

PCR and APEX 

1 month 

2 micrograms DNA 

CF Network - 2004 

 

390

Cystinuria gene (1SLC3A1)  

104614 

ATR1, D2H, RBAT, CSNU, CSNU1 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

980

Cystinuria gene 2 (SLC7A9)  

604144 

CSNU3 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1290

Deafness Autosomal Dominant Nonsyndromic Sensorineural 9  

601369 

COCH 

P51S 

 

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Deafness neurosensory, autosomal dominant low frequencies  

600965 

WFS1 

exon 8 

Sequencing (exon 8)  

< 2 months 

2 micrograms DNA 

 

in preparation 

800

Deafness nonsyndromic (DFNB1) _(DFNA2)  

220 290 600 101 

GJB2, GJB3, GJB6, GJA1, SLC26A5, SLC26A4, mtDNA 

201 mutations 

PCR and APEX 

1 month 

2 micrograms DNA 

 

 

390

Deafness, DFNA3 

220290 

GJB2 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

990

Deafness, maternally inherited 

520000 

DNA MITOCHONDRIAL  

A1555G 

RFLP's 

15 days  

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

320

Dejernie - sottas (HMSNIII) , DSDA 

145900 

PMP22 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

990

Dejernie - sottas (HMSNIII) , DSDB 

145900 

MPZ 

whole gene 

Sequencing 

45 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1390

Dentatorubro - pallidoluyisian atrophy (DRPLA)  

125370 

DRPLA 

REPEAT 

Fragments analysis  

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

540

Denys - Drash syndrome 

#194080 

WT1 

C360G R362X R366H H373Q H377Y R394W R394P D396G D396N 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

320

Detection of high - risk types of HPVs in cervical cells  

603956 

HPV 

 

DNA - Microarrays 

1 week 

2 micrograms DNA 

 

CAP 

180

DFNB1  

121011 

OGJB2 

all coding sequence 

polymerase chain reaction sequence analysis restriction enzyme detection 

15days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

775

Di George syndrome, velocardiofacial syndrome 

188400, 192430 

 

 

fluorescent PCR 

prenatal: 2 weeks; postnatal: 4 weeks 

2 micrograms DNA 

 

 

1 person postnatal 250 - 3 persons postnatal 380 - only fetus 350 - fetus+parents 460

Di George, syndrome 

188400 

REGION 22q11.2 

deletion 

MLPA 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

540

Dihydropyrimidine Dehydrogenase Deficiency (5 - Fluoro - Uracil Pharmacogenetics)  

274270 

DPYD 

*2A (IVS14+ 1G>A)  

TaqMan 

3 - 5 days 

 

Medical University Graz 

EMQN, ÖQUASTA , DGKL , INSTAND  

90

DNA repair  

 

NAT1, NAT2, CYP2D6, CYP1B1, CYP1A1, CYP1A2, ATM, BRCA1, BRCA2, p16, CDKN1a, CDKN2A, etc..(106 genes) 

228 mutations 

PCR and APEX 

1 month 

13 micrograms DNA 

 

ISO 9001:2000 

390

Duchenne Muscular Dystrophy (DMD)  

300 376 310 200 

Dystrophin 

exon 3, 4, 6, 8, 12, 13, 16, 17, 19, 32, 34, 41, 42, 43, 44, 45, 47, 48, 49, 50, 51, 52, 60, pb pm 

Multiplex PCR 

1 month 

2 micrograms DNA 

EMQN - 2005 

 

410

Dysautonomia 

223900 

IKBKAP 

2507+ 6 T>C 

 

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Dystonia, progressive with diurnal variation  

128230 

DYT5 

all coding exons 

Sequencing (all coding exons)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

Early - onset nephrotis syndrome Sclerosis mesangial diffuse 

#256370 

WT1 

H377Y F383L D396N 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

320

Ehlers Danlos type IV, vascular type  

130050 

COL3A1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2500

Epidermolysis bullosa dystrophica dominant  

131750 

COL7A 

 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epidermolysis bullosa dystrophica recessive  

226600 

COL7A1 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epidermolysis bullosa dystrophica with subcorneal cleavage  

607600 

COL7A1 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epidermolysis bullosa pretibial  

131850 

COL7A1 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epidermolysis bullosa pruriginosa, autosomal dominant and recessive  

604129 

COL7A1 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epidermolysis bullosa with congenital localized absence of skin and deformity of nails  

132000 

COL7A1 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

 

 

4300

Epithelial sodium channel, beta subunit (SCNN1B)  

600760 

SCNEB 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1290

Epithelial sodium channel, gamma subunit (SCNN1G)  

600761 

SCNEG 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1290

ERCC1 

*126380 

ERCC1  

Asn118Asn 

Sequencing 

1 week 

2 micrograms DNA 

 

 

110

ERCC2_XPD - Asp312Asn 

#278730 

ERCC2/ XPD 

Asp312Asn 

Sequencing 

1 week 

2 micrograms DNA 

 

 

110

ERCC2_XPD - Lys751Gln 

#278730 

ERCC2/ XPD 

Lys751Gln 

Sequencing 

1 week 

2 micrograms DNA 

 

 

110

Exostoses Multiple type I  

133700 

EXT1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2400

Exostoses Multiple type II  

133700 

EXT2 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2600

Factor V Deficiency 

227400 

F5 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Factor V Deficiency 

227400 

F5 

Full gene analysis 

dHPLC & Sequencing 

40 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

2800

Factor VII Deficiency 

227500 

F7 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Factor VII Deficiency 

227500 

F7 

Full gene analysis 

dHPLC & Sequencing 

30 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

1100

Factor X Deficiency 

227600 

F10 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Factor X Deficiency 

227600 

F10 

Full gene analysis 

dHPLC & Sequencing 

30 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

1100

Factor XI Deficiency 

264900 

F11 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Factor XI Deficiency 

 

F11 

Ashkenazi Jewish type II & type III mutations 

PCR & Sequencing 

20 days 

2 micrograms DNA 

 

 

430

Factor XI Deficiency 

264900 

F11 

Full gene analysis 

dHPLC & Sequencing 

30 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

980

Factor XII 

134570 

F12 

C46CT 

 

20 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Familial adenomatous polyposis coli, MYH, MUTYH associated Polyposis (MAP)  

*604933 

MUTYH 

Sequencing 

Sequencing 

 

2 micrograms DNA 

 

 

1330

Familial dysautonomia 

223900  

IKBKAP  

2507+ 6 T>C  

RFLP 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Familial gastric cancer diffuse  

192090 

CDH1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

6500

Familial Hypercholesterolemia 

114010 

LDL + ApoB 

208 MUTATION + Sequencing+ REARRANGEMENTS 

Microarrays+ Sequencing 

2 months 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1900

Familial Hypercholesterolemia (Apolipoprotein E isoforms)  

107741 

APOE 

e2/ e3/ e4 subtypes 

TaqMan 

3 - 5 days 

2 micrograms DNA 

ÖQUASTA , DGKL  

EMQN, ÖQUASTA , DGKL , INSTAND  

90

Familial Hypercholesterolemia (Defective Apolipoprotein B)  

144010 

APOB 

R3500Q 

TaqMan 

3 - 5 days 

2 micrograms DNA 

ÖQUASTA, DGKL  

EMQN, ÖQUASTA , DGKL , INSTAND  

100

Familial hyperinsulinism 

256450 

ABCC8 

IVS32-9G>A, deltaF1388 

RFLP 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Familial malignant melanoma 

155601 

p16 (CDKN2A) 

whole gene 

Sequencing 

20-30 days 

2 micrograms DNA 

 

 

440

Familial meditarranean fever 

608107 

MEFV 

E148Q 

RFLP's 

20 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Familial meditarranean fever 

608107 

MEFV 

exon 10 

Sequencing 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

390

Familial Mediteranean Fever (MEFV) 

249100 

(MEFV) 

whole gene 

Sequencing 

20 days 

2 micrograms DNA 

 

 

450

Familial Mediterranean Fever  

249100 

MEFV 

10 mutations M680I, V726A, M694V, M694I, K695R, A744S, R761H, 692delI, A653H y A408G  

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

440

Familial mediterranean fever Recurrent polyserositis Familial paroxismal polyserositis 

#249100 

MEFV 

E148Q E148V E163A E319K I591T M694V E319K I591T M694V 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

320

Familial spastic paraplegia type I 

 

L1CAM 

 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

580

Familial spastic paraplegia type II SPG2, SPPX2 

#312920 

PLP1 (lipophilin)  

H139Y S169F F236S I186T  

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

580

Familial spastic paraplegia type III SPG3 Strumpell Disease 

#182600 

SPG3A (atlastin)  

R217Q R239C 

DNA extraction + amplification + sequence 

2 months 

2 micrograms DNA 

 

 

580

Familial spastic paraplegia type IV SPG4 

#182601 

SPG4 (spastin)  

S44L P45Q K299X 344K S362C N386S D441G C448Y D470V T1520del R499C AÆG nt 1620 Expansion (CAG) n R562E A578ins GÆC 1853+ 1IVS 9+ 4 AÆG 1 bp ins 

DNA extraction + amplification + sequence 

5 months 

2 micrograms DNA 

 

 

2400

Familial spastic paraplegia type VI SPG6 

#600363 

NIPA1 

T45R 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

250

Familial spastic paraplegia type VII SPG7 

#607259 

SPG7 (paraplegin)  

784 del 2 bp A2228del 9,5 Kb del 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

400

Familial spastic paraplegia type X SPG10 

#604187 

KIF5A 

N256S R280C 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

275

Familial spastic paraplegia type XIII SPG13 

#605280 

HSP60 (chaperonin)  

V72I 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

275

Familial spastic paraplegia type XVII SPG17 Silver syndrome 

#270685 

BSCL2 (seipin)  

N88S S90L 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

275

Familial spastic paraplegia type XXI SPG21 

 

ACP33 (maspardin)  

A601ins 

DNA extraction + amplification + sequence 

30 days 

2 micrograms DNA 

 

 

275

Fanconi anemia complementation group C 

227645  

FACC  

IVS4+ 4A>T  

ASO 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Fibrinogenaemia (Dys - , Hypo - and A)  

202400 

FGA, FGB & FGG 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Fibrinogenaemia (Dys - , Hypo - and A)  

202400 

FGA, FGB & FGG 

Full gene analysis 

dHPLC & Sequencing 

60 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

3400

Follicular Lymphoma 

 

BCL2/ JH t(14; 18) translocation 

 

PCR 

5 days 

4 micrograms DNA 

 

ISO 15189 

290

Fragile site rare (FRAXE)  

309548 

FMR - 2 

repeats 

 

2 weeks 

2 micrograms DNA 

 

 

170

Frasier syndrome 

#136680 

WT1 

R390X F392L 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

320

Galactosemia 

#230400 

GALT 

(all coding sequence)  

polymerase chain reaction sequence analysis restriction enzyme detection 

7 - 10days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

770

Galactosemia  

230400 

GALT 

mutation Q188R  

PCR and RFLP 

1 month 

2 micrograms DNA 

 

 

210

Gaucher Disease 

230800 

GBA 

R496H, N370S, 84GG, L444P, IVS2+1 

ASO 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Gaucher Disease (GBA) 

230800 

GBA 

whole gene 

Sequencing 

7-10 days 

2 micrograms DNA 

 

 

850

Gefitinib resistance  

*131550 

EGFR 

exon 18 - 21 

TGCE 

3 weeks 

2 micrograms DNA 

 

 

300

Gene of autosomal recessive hypercholesterolemia (LDLRAP1)  

605747 

ARH, ARH1, ARH2, FHCB1, FHCB2, MGC34705 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

980

Glanzmann Thrombasthenia  

273800 

ITGA2B & ITGB3 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

Glanzmann Thrombasthenia  

273800 

ITGA2B & ITGB3 

Full gene analysis 

dHPLC & Sequencing 

60 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

2200

Glaucoma congenital  

231300 

CYP1B1 

all coding exons 

Sequencing (all coding exons)  

2 months 

2 micrograms DNA 

 

in preparation 

800

Glucokinase (GCK)  

138079 

GK, GLK, HK4 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1100

Glutathion - S - transferase M1  

138350 

GSTM1 

deletion 

 

1 week 

2 micrograms DNA 

 

 

195

Glutathion - S - transferase T1  

600436 

GSTT1 

deletion 

 

1 week 

2 micrograms DNA 

 

 

195

Glycogen storage disease, type 1a 

232200 

GSD1A 

R83C 

RFLP 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

GNAS complex locus (GNAS1)  

139320 

GNAS, NESP55, GS, XLAS, ALEX 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1500

Goldmann - Favre syndrome  

268100 

NR2E3 

all coding exons 

Sequencing (all coding exons)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

gonadal dysgenesis, XY female type; GDXY  

306100 

SRY 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

990

gonadal dysgenesis, XY female type; GDXY  

306100 

SRY 

presence/ absence 

PCR 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

440

Gorlin - Goltz syndrome  

109400 

PTCH 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2700

Growth hormone 1(GH1)  

139250 

GH, GHN, GHD 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

490

Haemophilia 

 

F8 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

 

320

Haemophilia 

 

F8 

IVS 22 & IVS 1 Inversions 

Direct detection by PCR 

20 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

 

430

Haemophilia A 

306700 

F8 

Full gene analysis 

dHPLC & Sequencing 

40 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

CPA UK and UKHCDO 

1280

Haemophilia A  

306700 

F8 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

CPA UK and UKHCDO 

320

Haemophilia B 

306900 

F9 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

CPA UK and UKHCDO 

320

Haemophilia B 

306900 

F9 

Full gene analysis 

dHPLC & Sequencing 

20 days 

2 micrograms DNA 

UK NEQAS Haemophilia Genetics  

CPA UK and UKHCDO 

880

Heart block Familial  

113900 

SCN5A 

Mutation hotspots 

Sequencing  

 

2 micrograms DNA 

ISO 17025 

ISO 17025 

3500

Hemochromatosis - C282 Y, H63D  

235200 

HFE 

C282 Y, H63D  

PCR, RFLP, 3% agarose gel, TBE 

2 weeks 

2 micrograms DNA 

Internal quality control 

ISO 15189 

80

Hemochromatosis - C282Y, H63D, S65C 

235200 

HFE 

C282Y; H63D; S65C 

PCR - RFLP 

1 week 

2 micrograms DNA 

 

CAP 

190

Hemochromatosis - HFE Sequencing 

235200 

HFE 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

EMQN 2005 

ISO 17025:2005 / EMQN  

1100

Hemoglobin beta locus - HBB - Total gene Sequencing 

141900 

HBB 

total gene 

Sequencing 

4 weeks 

2 micrograms DNA 

 

 

1900

Hemophila B ( IX FACTOR) 

306900 

IX FACTOR 

whole gene 

Sequencing 

20 days 

2 micrograms DNA 

 

 

575

Hemophilia A - FVIII  

306700 

FVIII 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2200

Hemophilia A ( VIII FACTOR) 

306700 

VIII FACTOR 

whole gene 

Sequencing 

30 days 

2 micrograms DNA 

 

 

675

Hemophilia B - FIX  

306900 

FIX 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

1100

Hereditary Fructose Intolerance  

229600 

ALDOB 

A149P, A174D, N334K 

TaqMan 

3 - 5 days 

 

 

EMQN, ÖQUASTA , DGKL , INSTAND  

150

Hereditary Fructose Intolerance  

229600 

ALDOB 

all exons and exon - intron boundaries 

Sequencing of all exons and exon - intron boundaries 

3 - 4 weeks 

 

 

EMQN, ÖQUASTA , DGKL , INSTAND  

1100

Hereditary liability to pressure palsy (HNPP)  

159440 

MPZ 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

540

Hereditary Non Polyposis Colon Cancer (HNPCC) - MLH1 

120436 

MLH1 

whole gene  

Sequencing + MLPA 

20-30 days 

2 micrograms DNA 

 

 

650

Hereditary Non Polyposis Colon Cancer (HNPCC) - MLH1, MSH2, MSH6  

114400 

MSH2, MLH1 and MSH6 full genes screening 

TGCE (Temperature Gradient Capillary Electrophoresis; Transgenomics Inc.) + analysis of all exons and exons - introns boundaries with bidirectional sequencing of all variant profiles + MLPA (Multiplex Ligation-dependent Probe Amplification; MRC Holland) for major deletions or insertions. 

 

2 months 

2 micrograms DNA 

EMQN 

EMQN 

1200 Euro for 0 - 10 samples per month; 1150 Euro for 11 to 100 samples per month; 950 Euro for 101 samples per month and above

Hereditary Non Polyposis Colon Cancer (HNPCC) - MSH2 

120435 

MSH2 

whole gene  

Sequencing + MLPA 

20-30 days 

2 micrograms DNA 

 

 

650

Hereditary Non Polyposis Colon Cancer (HNPCC) - PMS2 

*120435 

PMS2 

Sequencing 

Sequencing 

 

2 micrograms DNA 

 

 

1280

Hereditary progressive dystonia  

128230 

GTP - CHI  

point mutation 

PCR - SSCP - DNA 

3 weeks 

2 micrograms DNA 

 

CAP 

490

Homocystinuria  

603174 

CBS 

exon 4, exon 8 

Sequencing (exon 4, exon 8)  

< 2 months 

2 micrograms DNA 

 

in preparation 

400

HYDROXYLASE 21 - Deficiency 

201910 

(CYP21A2) 

P30L Exon 1 - C -> T nucleotidic position 89; Pro ® Leu codon ; level 30 / A/C-655 ->G Intron 2 A/C -> G nucleotidic position 655 / N172I Exon 4 -T -> A nucleotidic position 999;Asn -> Ile codon level 172 / V281L Exon 7 G -> T nucleotidic position 1683; Val -> Leu codon level 281 / Q318X -Exon 8 C -> T nucleotidic position 1993;Gln ->Stop a codon level 318 / W356R Exon 8 C -> T nucleotidic position 2108; Trp -> Arg codon level 356. 

C -> T nucleotidic position 2108; Trp -> Arg codon level 356. 

15 days 

2 micrograms DNA 

 

 

345

Hypercholesterolemia  

#143890  

LDLR 

D245E 

TGCE 

2 weeks 

2 micrograms DNA 

 

 

110

Hypertrophic Cardiomyopathy Familial  

192600 

ACTC, MYL2, MYL3, MYH7, MYBPC3, TNNT2, TNNI3, TPM1 

106 Exons 

Sequencing  

 

10 micrograms DNA 

CLIA 

CLIA 

3000

Hypobetalipoproteinemia Familial 

107730 

APOB 

whole gene 

Sequencing  

3 months 

2 micrograms DNA 

ISO 17025 

ISO 17025 

4800

Hypochondroplasia 

146000 

FGFR3 

Sequencing 

Sequencing 

 

2 micrograms DNA 

 

 

2100

Hypochondroplasia - R3500Q, R3531C 

146000 

FGFR3 

R3500Q and R3531C 

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

395

I factor (CFI )  

217030 

IF, FI, KAF, C3B - IN 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1100

Ichthyosis congenita harlequin fetus type  

242500 

ABCA12 

whole gene 

Sequencing  

4 months 

2 micrograms DNA 

CLIA 

CLIA 

5700

Ichthyosis, X linked 

308100 

Xp22.32 

deletions 

MLPA 

25 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

440

Inclusion body myopathy  

600737 

GNE 

all coding exons 

Sequencing (all coding exons)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

Incontinentia Pigmenti - Chromosome X inactivation 

308300 

IKBKG 

Chromosome X inactivation 

 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

395

Incontinentia Pigmenti - deletion exons 4 - 10 

308300 

IKBKG 

deletion exons 4 - 10 

PCR 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

395

Infantile Epilepsy, CDKL5 

600185 

CDKL5 

 

PCR 

 

2 micrograms DNA 

 

 

980

Infantile spasm syndrome X - linked  

308350 

ARX 

429 - 452dup en (GCG) 10+ 7 insertion 

 

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Jackson - Weiss syndrome 

#123150 

FGFR2 

A344G 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

240

k - ras activation 

#260350, #114500, #211980 

KRAS2 

codons 12, 13 

TGCE 

2 weeks 

2 micrograms DNA 

 

 

110

Kearns - Sayre syndrome 

530000 

POLG1, Twinkle, ANT1 

 

 

 

2 micrograms muscle DNA 

 

 

290

Kostmann disease, Severe Congenital Neutropenia  

202700 

ELA2 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

990

Lactose Intolerance (adult type hypolactasia)  

223100 

LCT 

- 13910T>C 

TaqMan 

3 - 5 days 

 

INSTAND  

EMQN, ÖQUASTA , DGKL , INSTAND  

90

LCHAD deficiency  

609016 

HADHA 

mutation G1528C  

PCR and RFLP 

1 month 

2 micrograms DNA 

 

 

210

Leber congenital amaurosis (LCA1)  

204000 

CRB1, AIPL1, GUCY2D, CRX, RPE65, RPGRIP1, MERTK, LRAT 

344 positions 

PCR and APEX 

1 month 

2 micrograms DNA 

 

 

390

Leber optic atrophia - G11778A 

516000 

MTND1 

G11778A 

 

1 week 

2 micrograms DNA 

 

 

280

Leber optic atrophy  

535000 

mtDNA 

11778 G>A, 3460 G>A, 14484 T>C, 15257 A>G 

 

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Leigh mitoncondrial syndrome  

516060 

MTATP6 

8993T>G y 8993TàC  

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

290

Leopard syndrome 

151100 

PTPN11 

mutation screening of exons 2,3,4,7,8,12,13 

CSGE + Sequencing 

30 - 40 days 

5 micrograms DNA 

 

EMQN 

890

Li - Fraumeni - Syndrom 

*151623 

p53 

whole gene 

Sequencing 

20-30 days 

2 micrograms DNA 

 

 

440

Lipoprotein lipase (LPL)  

238600 

LIPD, FCHL 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1100

Long QT syndrome 3 (LQT3)  

603830 

SCN5A 

Mutation hotspots 

Sequencing  

 

2 micrograms DNA 

ISO 17025 

ISO 17025 

3500

Low density lipoprotein receptor LDLR 

143890 

LOW DENSITY LIPOPROTEIN RECEPTOR 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1880

Lowe syndrome  

309000 

OCRL1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

3250

Lymphoma, Acute leukemia  

 

IgH gene rearrangement(VH - FR1 - 3 and DH1 - 7 to JH genes)  

 

multiplex PCR 

10 days 

4 micrograms DNA 

 

ISO 15189 

400

Lymphoma, Acute leukemia  

 

TCR gamma (T cell receptor gamma) gene rearrangement (V?1 - 11genes to all J? exons: J?1.1/ 2.1 and J?1.3/ 2.3)  

 

multiplex PCR 

10 days 

4 micrograms DNA 

 

ISO 15189 

400

Machado - Joseph Disease  

109150 

ATX3 

(repeat)  

PCR  

< 2 months 

2 micrograms DNA 

EMQN 

in preparation 

400

Male Infertility (Oligospermia - Azoospermia, Sertoli - cell - only syndrome) )  

415000 

AZFa AZFb AZFc (including DAZ and KALY)  

microdeletions  

multiplex PCR 

5 days 

2 micrograms DNA 

 

 

350

Male Infertility (Oligospermia - Azoospermia, Sertoli - cell - only syndrome) )  

415000 

AZFa, AZFb, AZFc  

microdeletions  

multiplex PCR 

5 days 

3 micrograms DNA 

 

ISO 15189 

175

Maple syrup urine disease 

248611 

BCKDHB 

R183P 

RFLP 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Marfan type 1 syndrome  

154700 

FBN1 

Exons 13, 15, 21, 23, 24, 25, 26, 27, 28, 43, 44, 55, 62, 63 and 65 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

2600

Marfan type 1 syndrome - all coding exons 

154700 

FBN1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

8800

Marfan type 2 syndrome  

154705 

TGFBR2 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

1200

Marshall syndrome  

154780 

COL11A1 

whole gene 

Sequencing  

8 months 

10 micrograms DNA 

 

 

4000

May - Hegglin anomaly 

155100 

MYH9 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

320

May - Hegglin anomaly 

 

MYH9 

Analysis for known mutations 

usually PCR & Sequencing 

10 days 

2 micrograms DNA 

 

 

320

May - Hegglin anomaly 

155100 

MYH9 

Full gene analysis 

dHPLC & Sequencing 

40 days 

2 micrograms DNA 

 

CPA UK and UKHCDO 

4300

May - Hegglin anomaly 

 

MYH9 

Targeted analysis - exons 25, 38 & 40 

PCR & Sequencing 

20 days 

2 micrograms DNA 

 

 

750

Medullary thyroid carcinoma  

155240 

RET 

Sequencing (exons 10, 11, 12, 13, 14, 16)  

Sequencing (exons 10, 11, 12, 13, 14, 16)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

800

MELAS - Mitochondrial myopathy encephalopathy lactic acidosis and strokelike episodes  

540000 

MTTL1 

all coding exons (3243A>G, 3271T>C y 3252A>G )  

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

395

Membrane cofactor protein (MCP)  

120920 

CD46, MIC10, TLX, MGC26544, TRA2.10 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1250

Mental retardation 1  

 

SWH, SCC, SLG, SW, SRT, SD, SK* 

deletions / DUPLICATIONS  

MLPA 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

440

Mental retardation 2  

 

DIGEORGE, SOTOS , KABUKI, ALAGILLE,  

deletions / DUPLICATIONS  

MLPA 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

440

Mental retardation nonspecific (X-linked) MRX - Panel  

 

ARX, PQBP1, JARID1C, TM4SF2, FACL4, DLG3, FTSJ1 , ZNF41 

 

Sequencing  

4 months 

2 micrograms DNA 

CLIA 

CLIA 

4000

Mental retardation X-linked 

 

X CHROMOSOME 

deletions / DUPLICATIONS 

MLPA 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

440

Mental retardation, congenital anomalies 

 

 

Identification of submicroscopic gains and losses up to 3Mbp in cases with normal karyotype 

High Resolution Metaphase Comparative Genome Hybridization (HR - CGH)  

15 days 

10 micrograms DNA 

 

ISO 15189 

460

MERRF - Myoclonic epilepsy associated with ragged - red fibers  

545000 

MTTK 

8344A>G, 8356T>C y 8363G>A  

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

395

Mineralocorticoid receptor (NR3C2)  

600983 

MLR, HMR, MCR, MR 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1450

Mitochondrial Panel 1 and Panel 2 : MELAS; MERRF; NARP; Cardiomyopathy & deafness; Diabetes & deafness; Leigh syndrome + MNGIE (multiple mtDNA deletions); Ocular and skeletal myopathy  

516060, 520000, 530000, 540000, 545000, 551500, 590060 

mtDNA 

point mutations (A3243G, T3271C, A8344G, G8363A, T8993C, T8993G, T9176C, G13513A, T14709C), deletions 

PCR and ASO and/or RFLP and Southern blot hybridization 

2-3 weeks 

20 micrograms DNA (blood or muscle), muscle biopsy: 50 mg frozen 

 

CLIA 

1125; more than 25 samples a month 1025

Mitochondrial Panel 1 and Panel 2 expanded : MELAS; MERRF; NARP; Diabetes & deafness; Cardiomyopathy & deafness; Leigh syndrome + MNGIE (multiple mtDNA deletions); Ocular and skeletal myopathy; + KSS; Pearson's marrow - pancreas syndrome; PEO  

516060, 520000, 530000, 540000, 545000, 551500, 557000, 590060 

mtDNA 

point mutations (A3243G, T3271C, A8344G, G8363A, T8993C, T8993G, T9176C, G13513A, T14709C), deletions, duplications 

PCR and ASO and/or RFLP and Southern blot hybridization 

2-3 weeks 

20 micrograms DNA (blood or muscle), muscle biopsy: 50 mg frozen 

 

CLIA 

1250; more than 25 samples a month 1150

Mitochondrial Panel 1 or 2 further investigations: MtDNA mutation quantitation 

 

mtDNA 

quantitate a single mtDNA Panel 1 point mutation or Panel 2 RFLP in additional family member 

PCR and ASO and/or RFLP 

2-3 weeks 

2 micrograms DNA 

 

CLIA 

345; more than 25 samples a month 300

Mitochondrial Panel 2 expanded : MNGIE (multiple mtDNA deletions); Ocular and skeletal myopathy + KSS; Pearson's marrow - pancreas syndrome; PEO 

530000, 557000 

mtDNA 

deletions, duplications 

Southern blot hybridization 

2-3 weeks 

20 micrograms DNA (blood or muscle), muscle biopsy: 50 mg frozen 

 

CLIA 

625; more than 25 samples a month 575

Mitochondrial Panel 2 further investigations : Special sequencing 

 

mtDNA 

sequencing a limited region to identify change detected in Mitochondrial DNA Panel 2 

Sequencing and PCR and RFLP 

2-3 weeks 

2 micrograms DNA 

 

CLIA 

345; more than 25 samples a month 300

Mitochondrial encephalopathy, lactic acidosis, stroke - like episodes,MELAS 

535000 

mtDNA tRNA Leu  

 

 

 

2 micrograms muscle DNA 

 

 

290

Mitochondrial Panel 1 : MELAS; MERRF; NARP; Diabetes & deafness; Cardiomyopathy & deafness; Leigh syndrome 

516060, 520000, 540000, 545000, 551500, 590060 

MTTL1, MTTE, MTTK, MTATP6, MTND5 

A3243G, T3271C, A8344G, G8363A, T8993C, T8993G, T9176C, G13513A, T14709C 

PCR and ASO and/or RFLP 

2-3 weeks 

2 micrograms DNA (blood or muscle), muscle biopsy: 50 mg frozen 

 

CLIA 

725; more than 25 samples a month 675

Mitochondrial Panel 2 : MNGIE (multiple mtDNA deletions); Ocular and skeletal myopathy 

530000 

mtDNA 

deletions 

Southern blot hybridization 

2-3 weeks 

20 micrograms DNA (blood or muscle), muscle biopsy: 50 mg frozen 

 

CLIA 

495; more than 25 samples a month 450

MLH1 Sequencing + MLPA 

114500 

MLH1  

whole gene 

Sequencing + MLPA 

6 weeks 

2 micrograms DNA 

ISO 15189 

ISO 15189 

950

MODY1 - Maturity Onset Diabetes of the Young, type 1  

125850 

HNF4 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

EMQN 2006 

ISO 17025:2005 / EMQN  

1300

MODY2 - Maturity Onset Diabetes of the Young, type 2  

125851 

GCK 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

EMQN 2006 

ISO 17025:2005 / EMQN  

1300

MODY3 - Maturity Onset Diabetes of the Young, type 3  

600496 

TCF1 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

EMQN 2006 

ISO 17025:2005 / EMQN  

1300

Monilethrix  

158000 

KRTHB1+ KRTHB6 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

5450

Morbus Gilbert  

143500 

UGT1A1 

UGT1A1 6/ 7TA 

PCR, 12% PAGE, ETB 

3 weeks 

2 micrograms DNA 

DGKL (BRD) , ÚHKT (Prague - CZ)  

ISO 15189 

110

Morning - Glory syndrome 

 

PAX6 

P68S 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

275

MSH6 Sequencing + MLPA 

600678 

MSH6 

whole gene 

Sequencing + MLPA 

6 weeks 

2 micrograms DNA 

ISO 15189 

ISO 15189 

880

MTHFR - A 1298C 

*607093 

MTHFR 

A 1298C 

RT - PCR on Rotor - Gene 3000 (Corbett Reaserch) , CE kits (allelic discrimination)  

2 weeks 

2 micrograms DNA 

CSN EN ISO 15189 / ÚHKT (Prague - CZ)  

ISO 15189 

55

Mucolipidosis type 4 

252650 

MCOLN1 

IVS3-2A>3, 511del6434 

RFLP 

3 weeks 

5 micrograms DNA 

NYS-DOH 

CLIA NYS-DOH CAP 

1-20 samples a month 135; 21-100 samples a month 115; over 100 samples a month 95

Muenke syndrome 

#602849 

FGFR3 

P250R 

DNA extraction + amplification + sequence 

20 days 

2 micrograms DNA 

 

 

240

Multiple drug resistance  

*171050  

MDR1 

C3435T 

Sequencing 

1 week 

2 micrograms DNA 

 

 

110

Multiple Endocrine Neoplasia 

131100 

RET 

T918C 

RFLP's 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Multiple Endocrine Neoplasia 

131100 

RET 

C634A 

RFLP's 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

290

Multiple Endocrine Neoplasia 

131100 

RET 

EXONS 10 AND 11 

Sequencing 

30 days 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

4900

Multiple Endocrine Neoplasia 

131100 

RET 

EXONS 13,14,16 

Sequencing 

3 months 

2 micrograms DNA 

AEGH 

ISO 17025 EN PROCESS 

1390

Multiple Endocrine Neoplasia type 1  

131100 

MEN1 

Sequencing (all coding exons)  

Sequencing (all coding exons)  

2 - 4 months 

2 micrograms DNA 

 

in preparation 

400

Multiple Endocrine Neoplasia type 2A  

171400 

RET 

Sequencing (exon 10 and 11)  

Sequencing (exon 10 and 11)  

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Multiple Endocrine Neoplasia type 2B  

162 300 

RET 

Sequencing (exon 16)  

Sequencing (exon 16)  

< 2 months 

2 micrograms DNA 

 

in preparation 

400

Myocilin (MYOC)  

601652 

TIGR, GLC1A 

Genomic Sequencing of the entire coding region 

Genomic Sequencing of the entire coding region 

2 - 4 weeks 

2 micrograms DNA 

 

DGKL,CAP 

1290

Myoclonus epilepsy, ragged red fibers , MERRF 

545000 

mtDNA tRNA Lys 

 

 

 

2 micrograms muscle DNA 

 

 

290

Myotonia Congenita Autosomal Dominant 

#160800 

CLCN1 

all coding sequence 

polymerase chain reaction sequence analysis  

60 days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

770

Myotonia Congenita Autosomal Recessive 

#105400 

CLCN1 

all coding sequence 

polymerase chain reaction sequence analysis  

60 days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

770

Myotubular Myopathy (MTM1)  

#310400 

Myotubularin 

all coding sequence 

polymerase chain reaction sequence analysis  

20 days 

4 micrograms DNA 

 

UNI EN ISO 9001 - CERMET / EMNQ, Istituto Superiore Sanità  

775

Nail - Patella syndrome  

161200 

LMX1B 

all coding exons 

Sequencing 

30 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

1200

NARP - Neuropathy, ataxia, and retinitis pigmentosa  

551500 

MTATP6 

8993T>G y 8993TàC  

Sequencing 

20 days 

2 micrograms DNA 

 

ISO 17025:2005 / EMQN  

295

NAT2  

243400 

NAT2 

NAT*5, NAT*6,NAT*7 

PCR - RFLP 

2 weeks 

2 micrograms DNA 

 

CAP 

330

NAT2 genotyping 

243400 

NAT2 

all coding exons 

Sequencing 

20 days 

2 micrograms DNA